Question special
Lead Moderator

I would like to piggyback off of the great question by Dr. Yarbrough below. As Dr. Talan points out, the fact that this was a research study allowed for greater resources in terms of reaching out to participants; however, the reality of the ED makes this difficult in practice. I am curious about your experiences with patient follow-up in the field of Emergency Medicine, and any innovative solutions that might be present at your institution. I can imagine this is especially important with "watch-and-wait" situations, or when patients are prescribed drugs with a higher risk profile than TMP-SMX.